Rationale for a novel immunotherapy of cancer with allogeneic lymphocyte infusion
- 1 November 1984
- journal article
- review article
- Published by Elsevier in Medical Hypotheses
- Vol. 15 (3) , 241-277
- https://doi.org/10.1016/0306-9877(84)90017-3
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Cytostatic and reverse-transforming therapies of cancer — A brieff review and future prospectsMedical Hypotheses, 1982
- The therapeutic potential of Glucose Tolerance FactorMedical Hypotheses, 1980
- Synergistic denaturant therapy — A general strategy for treatment of solid malignanciesMedical Hypotheses, 1980
- The reversibility of cancer: The relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1Medical Hypotheses, 1980
- Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced CancerNew England Journal of Medicine, 1979
- Prostaglandin-Producing Suppressor Cells in Hodgkin's DiseaseNew England Journal of Medicine, 1977
- Vitamin C and the immune responseCellular and Molecular Life Sciences, 1977
- Increased immunogenicity of ehrlich ascites cells after heat treatmentCancer, 1972
- Prolonged Skin Allograft Survival in Vitamin C-Deficient Guinea-PigsEuropean Surgical Research, 1972
- Cancer Immunity—Hypothesis and Clinical Trial of Lymphocytotherapy for Malignant DiseasesAnnals of Surgery, 1970